Our expert editorial board consists of psychiatrists from around the world who are respected and recognized researchers and clinicians.
The founder of PL is Nassir Ghaemi MD MPH, Professor of Psychiatry, Tufts University School of Medicine; Lecturer on Psychiatry, Harvard Medical School, Boston, USA; Director-Translational Medicine, Novartis Institutes for Biomedical Research, Cambridge MA (since October 2017).
Dr Ghaemi is an expert in manic-depressive illness, and has published over 200 scientific articles, and over half a dozen books. His complete biography, with links to his books, is available here.
Disclaimer: All views expressed here by Dr. Ghaemi solely are his own, and do not reflect those of any of his employers. Novartis does not actively market any drugs in psychiatry at the present time, but it does manufacture and sell trade versions of the following generically available psychiatric drugs: carbamazepine, clozapine, methylphenidate, clomipramine, and imipramine. Its subsidiary Sandoz manufactures a generic form of sertraline.
Our editorial board members review content for independence and objectivity. They are:
Andrea Amerio MD, Research psychiatrist, University of Parma, Italy.
Dr. Amerio is an active researcher in anxiety and mood conditions.
Sergio Barroilhet MD, PhD, Assistant Professor of Psychiatry, Director of Psychosomatic Medicine Unit, University Psychiatric Clinic, University of Chile, Santiago. Research Instructor Adjunct of Tufts Medicine School. Clinical Researcher, Mood Disorders Program, Tufts Medical Center, Boston USA.
Dr. Barroilhet has expertise in borderline personality and bipolar illness, and is an active clinician.
Anthony Joseph MD, Associate Clinical Professor of Psychiatry, McLean Hospital, Harvard Medical School, Boston, USA
Dr. Joseph is an Associate Clinical Professor of Psychiatry at Harvard Medical School and McLean Hospital. He specializes in the neurology and psychopharmacology of behavior disturbance, violence and cognitive rehabilitation.
Sivan Mauer MD, Research psychiatrist, Tufts University School of Medicine, Boston. Private Practice, Curitiba, Brazil.
Dr. Mauer is an active researcher and clinician in mood conditions and dementias.
Gabriele Sani MD, Assistant Professor of Psychiatry, University of Rome, Italy.
Dr. Sani has expertise in mood conditions and conducts extensive research and clinical practice in that field.
Antonio Vela-Bueno MD, Professor of Psychiatry, University of Madrid, Spain.
Dr. Vela-Bueno is widely recognized internationally as an expert in sleep disorders, and has published hundreds of scientific articles. He also is on the faculty of the Harvard School of Public Health.
Derick Vergne MD, Clinical Assistant Professor of Psychiatry, Harvard Medical School
Dr. Vergne is an active clinician and researcher in substance abuse and in neuropsychiatry.
Paul Vohringer MD, MSc, MPH, Assistant Professor of Psychiatry, University of Chile, Santiago. Research Assistant professor of psychiatry at Tufts University School of Medicine
Dr. Vohringer has expertise in mood conditions and is a prominent researcher and clinician. He is director of the International Mood Network, a consortium of researchers.